wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38662690-D448DA22-1E0E-49D6-B3C8-90778F43B0A2
Q38662690-D448DA22-1E0E-49D6-B3C8-90778F43B0A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662690-D448DA22-1E0E-49D6-B3C8-90778F43B0A2
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes.
P2860
Q38662690-D448DA22-1E0E-49D6-B3C8-90778F43B0A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662690-D448DA22-1E0E-49D6-B3C8-90778F43B0A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
253e95e6c1113c91c6d586120af1efd76de1c2ab
P2860
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.